Value Aligned Research Advisors LLC Makes New Investment in Astera Labs, Inc. $ALAB

Value Aligned Research Advisors LLC purchased a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 568,316 shares of the company’s stock, valued at approximately $274,508,000. Astera Labs comprises approximately 0.7% of Value Aligned Research Advisors LLC’s holdings, making the stock its 24th biggest position. Value Aligned Research Advisors LLC owned 0.33% of Astera Labs as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in ALAB. Reflection Asset Management bought a new position in Astera Labs in the 4th quarter valued at approximately $25,000. Keating Financial Advisory Services Inc. bought a new stake in shares of Astera Labs in the 2nd quarter worth $25,000. Smartleaf Asset Management LLC increased its holdings in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new stake in shares of Astera Labs in the 4th quarter worth $33,000. Finally, Whipplewood Advisors LLC raised its stake in shares of Astera Labs by 15,950.0% in the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after purchasing an additional 319 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

NASDAQ ALAB opened at $304.09 on Friday. The business’s fifty day moving average price is $344.94 and its 200-day moving average price is $249.37. The stock has a market capitalization of $52.76 billion, a price-to-earnings ratio of 150.54 and a beta of 3.84. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same period last year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ALAB. Northland Securities raised Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target on the stock in a report on Monday, August 17th. Jefferies Financial Group lifted their price objective on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Roth Capital reissued a “buy” rating and issued a $450.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Needham & Company LLC upped their target price on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Finally, Barclays raised their price target on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $333.00.

Insider Buying and Selling

In other news, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the completion of the sale, the director owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. This represents a 9.62% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the company’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the sale, the director directly owned 75,688 shares of the company’s stock, valued at $26,882,106.96. The trade was a 11.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 419,244 shares of company stock valued at $163,135,169 in the last 90 days. Insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.